Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:ROKA
CUSIPN/A
Phone+1-908-6054700
Debt
Debt-to-Equity RatioN/A
Current Ratio1.25
Quick Ratio0.60
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$7.24 million
Price / Sales0.45
Cash FlowN/A
Price / CashN/A
Book Value$20.03 per share
Price / Book0.03
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-30,780,000.00
Net Margins3.30%
Return on Equity2.05%
Return on Assets1.00%
Miscellaneous
Employees90
Outstanding Shares5,010,000
Market Cap$3.25 million
Sorrento Tech (NASDAQ:ROKA) Frequently Asked Questions
What is Sorrento Tech's stock symbol?
Sorrento Tech trades on the NASDAQ under the ticker symbol "ROKA."
How were Sorrento Tech's earnings last quarter?
Sorrento Tech Inc (NASDAQ:ROKA) issued its quarterly earnings results on Thursday, May, 11th. The medical research company reported ($1.53) EPS for the quarter, missing analysts' consensus estimates of ($1.19) by $0.34. The medical research company earned $2.04 million during the quarter. Sorrento Tech had a return on equity of 2.05% and a net margin of 3.30%. View Sorrento Tech's Earnings History.
Who are Sorrento Tech's key executives?
Sorrento Tech's management team includes the folowing people:
- Paul G. Thomas, Chairman of the Board (Age 61)
- Mary Duseau, President, Chief Executive Officer, Secretary, Director (Age 52)
- Lars Boesgaard, Chief Financial Officer, Vice President, Treasurer (Age 47)
- Nicholas J. Valeriani, Director (Age 60)
- Michael P. Doyle Ph.D., Independent Director (Age 67)
- David W. J. McGirr, Independent Director (Age 62)
How do I buy shares of Sorrento Tech?
Shares of ROKA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Sorrento Tech's stock price today?
One share of ROKA stock can currently be purchased for approximately $0.65.
How big of a company is Sorrento Tech?
Sorrento Tech has a market capitalization of $3.25 million and generates $7.24 million in revenue each year. Sorrento Tech employs 90 workers across the globe.
What is Sorrento Tech's official website?
How can I contact Sorrento Tech?
Sorrento Tech's mailing address is 20 Independence Blvd, WARREN, NJ 07059-2731, United States. The medical research company can be reached via phone at +1-908-6054700 or via email at [email protected]
MarketBeat Community Rating for Sorrento Tech (NASDAQ ROKA)
MarketBeat's community ratings are surveys of what our community members think about Sorrento Tech and other stocks. Vote "Outperform" if you believe ROKA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ROKA will underperform the S&P 500 over the long term. You may vote once every thirty days.
